Stented endoscopic third ventriculostomy: technique, safety, and indications-a multicenter multinational study
Language English Country Germany Media print-electronic
Document type Journal Article, Multicenter Study
PubMed
39102023
PubMed Central
PMC11511752
DOI
10.1007/s00381-024-06566-7
PII: 10.1007/s00381-024-06566-7
Knihovny.cz E-resources
- Keywords
- Endoscopic third ventriculostomy, Hydrocephalus, Ommaya, Scarring, Stent,
- MeSH
- Hydrocephalus * surgery MeSH
- Humans MeSH
- Young Adult MeSH
- Neuroendoscopy * methods adverse effects MeSH
- Retrospective Studies MeSH
- Stents * adverse effects MeSH
- Third Ventricle * surgery MeSH
- Ventriculostomy * methods adverse effects MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Young Adult MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
PURPOSE: Endoscopic third ventriculostomy (ETV) is an effective treatment for obstructive hydrocephalus. Secondary stoma closure may be life threatening and is the most common reason for late ETV failure, mostly secondary to local scarring. Local stents intended to maintain patency are rarely used. In this study, we summarize our experience using stented ETV (sETV), efficacy, and safety. MATERIAL AND METHODS: Data was retrospectively collected from all consecutive patients who underwent ETV with stenting at four centers. Collected data included indications for using sETV, hydrocephalic history, surgical technique, outcomes, and complications. RESULTS: Sixty-seven cases were included. Forty had a primary sETV, and 27 had a secondary sETV (following a prior shunt, ETV, or both). The average age during surgery was 22 years. Main indications for sETV included an adjacent tumor (n = 15), thick or redundant tuber cinereum (n = 24), and prior ETV failure (n = 16). Fifty-nine patients (88%) had a successful sETV. Eight patients failed 11 ± 8 months following surgery. Reasons for failure included obstruction of the stent, reabsorption insufficiency, and CSF leak (n = 2 each), and massive hygroma and tumor spread (n = 1 each). Complications included subdural hygroma (n = 4), CSF leak (n = 2), and stent malposition (n = 1). There were no complications associated with two stent removals. CONCLUSION: Stented ETV appears to be feasible and safe. It may be indicated in selected cases such as patients with prior ETV failure, or as a primary treatment in cases with anatomical alterations caused by tumors or thickened tuber cinereum. Future investigations are needed to further elucidate its role in non-communicating hydrocephalus.
Department of Neurosurgery University Medicine Greifswald Greifswald Germany
Pediatric Neurosurgery Charité Universitaetsmedizin Berlin Berlin Germany
See more in PubMed
Kulkarni AV, Drake JM, Mallucci CL, Sgouros S, Roth J, Constantini S (2009) endoscopic third ventriculostomy in the treatment of childhood hydrocephalus. J Pediatr 155(2):254-259.e1. 10.1016/j.jpeds.2009.02.048 PubMed
Kulkarni AV, Riva-Cambrin J, Browd SR (2011) Use of the ETV success score to explain the variation in reported endoscopic third ventriculostomy success rates among published case series of childhood hydrocephalus. J Neurosurg Pediatr 7(2):143–146. 10.3171/2010.11.PEDS10296 PubMed
J. Lane, SHA Akbari (2022) ‘Failure of endoscopic third ventriculostomy’ Cureus10.7759/cureus.25136 PubMed PMC
Drake JM (2007) Endoscopic third ventriculostomy in pediatric patients. Neurosurgery 60(5):881–886. 10.1227/01.NEU.0000255420.78431.E7 PubMed
Hader WJ, Drake J, Cochrane D, Sparrow O, Johnson ES, Kestle J (2002) Death after late failure of third ventriculostomy in children. J Neurosurg 97(1):211–215. 10.3171/jns.2002.97.1.0211 PubMed
Marano PJ, Stone SSD, Mugamba J, Ssenyonga P, Warf EB, Warf BC (2015) Reopening of an obstructed third ventriculostomy: long-term success and factors affecting outcome in 215 infants. J Neurosurg Pediatr 15(4):399–405. 10.3171/2014.10.PEDS14250 PubMed
Hellwig D, Giordano M, Kappus C (2013) Redo third ventriculostomy. World Neurosurg 79(2):S22.e13-S22.e20. 10.1016/j.wneu.2012.02.006 PubMed
Siomin V et al (2001) Repeat endoscopic third ventriculostomy: is it worth trying? Child’s Nervous Syst 17(9):551–555. 10.1007/s003810100475 PubMed
Singhal A, Liu T, Cochrane D, Steinbok P (2010) Ventriculoperitoneal shunt after previous endoscopic third ventriculostomy: does ETV improve shunt survival? Cerebrospinal Fluid Res 7(S1):S14. 10.1186/1743-8454-7-S1-S14
Schulz M, Spors B, Thomale U-W (2015) Stented endoscopic third ventriculostomy—indications and results. Childs Nerv Syst 31(9):1499–1507. 10.1007/s00381-015-2787-2 PubMed
Roth J et al (2017) Endoscopic third ventriculostomy in patients with neurofibromatosis type 1: a multicenter international experience. World Neurosurg 107:623–629. 10.1016/j.wneu.2017.08.053 PubMed
Xiao B, Roth J, Udayakumaran S, Beni-Adani L, Constantini S (2011) Placement of Ommaya reservoir following endoscopic third ventriculostomy in pediatric hydrocephalic patients: a critical reappraisal. Childs Nerv Syst 27(5):749–755. 10.1007/s00381-010-1371-z PubMed